ETF Managers Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $48.3K | Buy |
+13,528
| New | +$48.3K | ﹤0.01% | 660 |
|
|
2022
Q4 | – | Sell |
-10,441
| Closed | -$23K | – | 559 |
|
|
2022
Q3 | $23K | Sell |
10,441
-734
| -7% | -$1.62K | ﹤0.01% | 686 |
|
|
2022
Q2 | $32K | Buy |
11,175
+1,541
| +16% | +$4.41K | ﹤0.01% | 727 |
|
|
2022
Q1 | $45K | Buy |
9,634
+32
| +0.3% | +$149 | ﹤0.01% | 660 |
|
|
2021
Q4 | $109K | Sell |
9,602
-1,320
| -12% | -$15K | ﹤0.01% | 631 |
|
|
2021
Q3 | $155K | Buy |
10,922
+1,654
| +18% | +$23.5K | ﹤0.01% | 622 |
|
|
2021
Q2 | $112K | Sell |
9,268
-7
| -0.1% | -$85 | ﹤0.01% | 620 |
|
|
2021
Q1 | $107K | Sell |
9,275
-5,452
| -37% | -$62.9K | ﹤0.01% | 634 |
|
|
2020
Q4 | $190K | Sell |
14,727
-1,804
| -11% | -$23.3K | ﹤0.01% | 576 |
|
|
2020
Q3 | $255K | Buy |
16,531
+8,446
| +104% | +$130K | 0.01% | 544 |
|
|
2020
Q2 | $189K | Buy |
+8,085
| New | +$189K | 0.01% | 560 |
|